{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:22:41Z","timestamp":1776118961103,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral venous sinus thrombosis (CVST) is a rare cause of cerebral infarction. Once patients survive the acute phase, long-term prognosis is generally satisfactory. CVST patients who harbored risk factors known for poor prognosis (e.g., deterioration of consciousness\/neurological functions and seizures) were oftentimes unresponsive to systemic heparin treatment. The advantage of combined endovascular mechanical thrombectomy (EMT) and on-site chemical thrombolysis (OCT) plus systemic heparin for CVST over the heparin treatment alone has not been proved. A retrospective study was conducted to analyze consecutive patients with CVST from 2005 to 2015. Patients having clinical improvement or stable disease after heparin treatment were in I\/S group; patients having continuous deterioration of consciousness\/neurological functions and refractory seizures (despite the use of multiple anti-epileptic drugs) after heparin treatment were in D group. EMT and OCT were indicated for patients in D group. Imaging studies and medical records were reviewed for statistical analysis. Safety issues included new-onset\/progression of symptomatic intracerebral hemorrhages (ICH) or procedure-related complications. Total thirty patients were included (I\/S group = 16; D group = 14). In D group, the mean time frame from the start of heparin treatment to the endovascular treatment was 3.2 days. Compared with I\/S group, all patients in D group had complete stenosis of the sinuses, with higher initial mRS, lower initial GCS, and more seizures (p\u2009=\u20090.006, 0.007, and 0.031, respectively), but no significant differences in the mRS at discharge (p\u2009=\u20090.504). Shorter length of thrombosis and lower initial mRS were associated with better outcomes (p\u2009=\u20090.009 and 0.003, respectively). Thrombosis involving the superior sagittal sinus (SSS) was associated with bad outcomes (p\u2009=\u20090.026). There were two patients (6.7%) with worsening symptomatic ICH, one in each group, managed surgically. The overall mortality of the study was 6.7% (2\/30). Combined EMT and OCT after heparin treatment for severe CVST were reasonably safe, which might be considered as a salvage treatment in severe CVST patients who are unresponsive to heparin with heavy clot burden involving SSS in the acute phase. However, further studies are needed to confirm its efficacy and validity.<\/jats:p>","DOI":"10.1038\/s41598-020-61884-5","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T12:46:08Z","timestamp":1584535568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Endovascular Mechanical Thrombectomy and On-Site Chemical Thrombolysis for Severe Cerebral Venous Sinus Thrombosis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3459-1913","authenticated-orcid":false,"given":"Chih-Hsiang","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nien-Chen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Chyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-7927","authenticated-orcid":false,"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuang-Seng","family":"Tsuei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"61884_CR1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1468-1331.2010.03011.x","volume":"17","author":"K Einhaupl","year":"2010","unstructured":"Einhaupl, K. et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur. J. Neurol. 17, 1229\u20131235, https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03011.x (2010).","journal-title":"Eur. J. Neurol."},{"key":"61884_CR2","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","volume":"42","author":"G Saposnik","year":"2011","unstructured":"Saposnik, G. et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42, 1158\u20131192, https:\/\/doi.org\/10.1161\/STR.0b013e31820a8364 (2011).","journal-title":"Stroke"},{"key":"61884_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ene.13381","volume":"24","author":"JM Ferro","year":"2017","unstructured":"Ferro, J. M. et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur. J. Neurol. 24, 1203\u20131213, https:\/\/doi.org\/10.1111\/ene.13381 (2017).","journal-title":"Eur. J. Neurol."},{"key":"61884_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","volume":"35","author":"JM Ferro","year":"2004","unstructured":"Ferro, J. M. et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35, 664\u2013670, https:\/\/doi.org\/10.1161\/01.STR.0000117571.76197.26 (2004).","journal-title":"Stroke"},{"key":"61884_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000487960","volume":"7","author":"SA Bushnaq","year":"2018","unstructured":"Bushnaq, S. A., Qeadan, F., Thacker, T., Abbas, M. & Carlson, A. P. High-Risk Features of Delayed Clinical Progression in Cerebral Venous Thrombosis: A Proposed Prediction Score for Early Intervention. Interv. Neurol. 7, 297\u2013307, https:\/\/doi.org\/10.1159\/000487960 (2018).","journal-title":"Interv. Neurol."},{"key":"61884_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000215942","volume":"28","author":"JM Ferro","year":"2009","unstructured":"Ferro, J. M. et al. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc. Dis. 28, 39\u201344, https:\/\/doi.org\/10.1159\/000215942 (2009).","journal-title":"Cerebrovasc. Dis."},{"key":"61884_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/neurintsurg-2015-012237","volume":"9","author":"DJ Lee","year":"2017","unstructured":"Lee, D. J. et al. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort. J. Neurointerv Surg. 9, 34\u201338, https:\/\/doi.org\/10.1136\/neurintsurg-2015-012237 (2017).","journal-title":"J. Neurointerv Surg."},{"key":"61884_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/jnnp.70.1.105","volume":"70","author":"SF de Bruijn","year":"2001","unstructured":"de Bruijn, S. F., de Haan, R. J. & Stam, J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J. Neurol. Neurosurg. Psychiatry 70, 105\u2013108 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"61884_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/STROKEAHA.107.502658","volume":"39","author":"J Stam","year":"2008","unstructured":"Stam, J., Majoie, C. B., van Delden, O. M., van Lienden, K. P. & Reekers, J. A. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke 39, 1487\u20131490, https:\/\/doi.org\/10.1161\/STROKEAHA.107.502658 (2008).","journal-title":"Stroke"},{"key":"61884_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clineuro.2015.04.013","volume":"134","author":"S Sari","year":"2015","unstructured":"Sari, S. et al. MRI diagnosis of dural sinus - Cortical venous thrombosis: Immediate post-contrast 3D GRE T1-weighted imaging versus unenhanced MR venography and conventional MR sequences. Clin. Neurol. Neurosurg. 134, 44\u201354, https:\/\/doi.org\/10.1016\/j.clineuro.2015.04.013 (2015).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"61884_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3171\/2014.9.JNS141813","volume":"123","author":"R Singh","year":"2015","unstructured":"Singh, R. et al. Isolated cortical vein thrombosis: case series. J. Neurosurg. 123, 427\u2013433, https:\/\/doi.org\/10.3171\/2014.9.JNS141813 (2015).","journal-title":"J. Neurosurg."},{"key":"61884_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1747-4949.2011.00753.x","volume":"8","author":"JM Coutinho","year":"2013","unstructured":"Coutinho, J. M. et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int. J. Stroke 8, 135\u2013140, https:\/\/doi.org\/10.1111\/j.1747-4949.2011.00753.x (2013).","journal-title":"Int. J. Stroke"},{"key":"61884_CR13","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1161\/hs1001.096192","volume":"32","author":"M Wasay","year":"2001","unstructured":"Wasay, M. et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 32, 2310\u20132317 (2001).","journal-title":"Stroke"},{"key":"61884_CR14","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMra042354","volume":"352","author":"J Stam","year":"2005","unstructured":"Stam, J. Thrombosis of the cerebral veins and sinuses. N. Engl. J. Med. 352, 1791\u20131798, https:\/\/doi.org\/10.1056\/NEJMra042354 (2005).","journal-title":"N. Engl. J. Med."},{"key":"61884_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-Q","volume":"338","author":"KM Einhaupl","year":"1991","unstructured":"Einhaupl, K. M. et al. Heparin treatment in sinus venous thrombosis. Lancet 338, 597\u2013600 (1991).","journal-title":"Lancet"},{"key":"61884_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/01.STR.30.3.484","volume":"30","author":"SF de Bruijn","year":"1999","unstructured":"de Bruijn, S. F. & Stam, J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30, 484\u2013488 (1999).","journal-title":"Stroke"},{"key":"61884_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/jnnp-2014-310068","volume":"87","author":"A Arauz","year":"2016","unstructured":"Arauz, A. et al. Time to recanalisation in patients with cerebral venous thrombosis under anticoagulation therapy. J. Neurol. Neurosurg. Psychiatry 87, 247\u2013251, https:\/\/doi.org\/10.1136\/jnnp-2014-310068 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"61884_CR18","doi-asserted-by":"publisher","unstructured":"Li, G. et al. Safety and validity of mechanical thrombectomy and thrombolysis on severe cerebral venous sinus thrombosis. Neurosurgery 72, 730\u2013738 discussion 730, https:\/\/doi.org\/10.1227\/NEU.0b013e318285c1d3 (2013).","DOI":"10.1227\/NEU.0b013e318285c1d3"},{"key":"61884_CR19","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.114.007465","volume":"46","author":"FM Siddiqui","year":"2015","unstructured":"Siddiqui, F. M. et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke 46, 1263\u20131268, https:\/\/doi.org\/10.1161\/STROKEAHA.114.007465 (2015).","journal-title":"Stroke"},{"key":"61884_CR20","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/neurintsurg-2016-012938","volume":"9","author":"A Ilyas","year":"2017","unstructured":"Ilyas, A. et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J. Neurointerv Surg. 9, 1086\u20131092, https:\/\/doi.org\/10.1136\/neurintsurg-2016-012938 (2017).","journal-title":"J. Neurointerv Surg."},{"key":"61884_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/ene.12901","volume":"23","author":"C Herweh","year":"2016","unstructured":"Herweh, C. et al. Frequency and temporal profile of recanalization after cerebral vein and sinus thrombosis. Eur. J. Neurol. 23, 681\u2013687, https:\/\/doi.org\/10.1111\/ene.12901 (2016).","journal-title":"Eur. J. Neurol."},{"key":"61884_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/1591019915583015","volume":"21","author":"M Mokin","year":"2015","unstructured":"Mokin, M. et al. Endovascular treatment of cerebral venous thrombosis: Contemporary multicenter experience. Interv. Neuroradiol. 21, 520\u2013526, https:\/\/doi.org\/10.1177\/1591019915583015 (2015).","journal-title":"Interv. Neuroradiol."},{"key":"61884_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neurad.2015.09.001","volume":"43","author":"A Lozano-Ros","year":"2016","unstructured":"Lozano-Ros, A. et al. Endovascular treatment of cerebral venous sinus thrombosis (CVST): Is a complete recanalization required for a good clinical outcome? J. Neuroradiol. 43, 51\u201354, https:\/\/doi.org\/10.1016\/j.neurad.2015.09.001 (2016).","journal-title":"J. Neuroradiol."},{"key":"61884_CR24","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1161\/STROKEAHA.113.004414","volume":"45","author":"JM Coutinho","year":"2014","unstructured":"Coutinho, J. M., Gerritsma, J. J., Zuurbier, S. M. & Stam, J. Isolated cortical vein thrombosis: systematic review of case reports and case series. Stroke 45, 1836\u20131838, https:\/\/doi.org\/10.1161\/STROKEAHA.113.004414 (2014).","journal-title":"Stroke"},{"key":"61884_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/0028-3886.141241","volume":"62","author":"SF Shui","year":"2014","unstructured":"Shui, S. F., Li, T. F., Han, X. W., Ma, J. & Guo, D. Balloon dilatation and thrombus extraction for the treatment of cerebral venous sinus thrombosis. Neurol. India 62, 371\u2013375, https:\/\/doi.org\/10.4103\/0028-3886.141241 (2014).","journal-title":"Neurol. India"},{"key":"61884_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00276-010-0714-5","volume":"33","author":"C Brockmann","year":"2011","unstructured":"Brockmann, C., Kunze, S. & Scharf, J. Computed tomographic angiography of the superior sagittal sinus and bridging veins. Surg. Radiol. Anat. 33, 129\u2013134, https:\/\/doi.org\/10.1007\/s00276-010-0714-5 (2011).","journal-title":"Surg. Radiol. Anat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61884-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:04:29Z","timestamp":1670313869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61884-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61884"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61884-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"20 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4937"}}